Song J Q, Bai D S, Hao C S, Wang H Y, Qiu Y, Niu Z S, Zhang C J, Liu X M
Department of Urology Surgery, the Children's hospital capital institute of pediatrics, Beijing 100020 China.
Zhonghua Yi Xue Za Zhi. 2020 Dec 1;100(44):3520-3524. doi: 10.3760/cma.j.cn112137-20200319-00839.
To Evaluate the clinic effect of two-staged laparoscopic Fowler-Stephens orchiopexy in the treatment of high cryptorchidism, and compare it with laparoscopic orchiopexy treatment without disconnecting spermatic vessels. A retrospective analysis was conducted on 20 cases of children with high cryptorchidism who were treated with two-staged Fowler-Stephens orchiopexy from January 2015 to April 2019 (F-S group). All the children in this group had unilateral cryptorchidism, age 6 to 18 months. The average age was 13.5 months. Seven cases were on the left side, and 13 cases were on the right side. There were 20 control children in the same age group who were treated with testicular fixation without disconnecting spermatic vessels, age 6 to 18 months. The average age was 12.5 months. Six cases were on the left side, and 14 cases were on the right side. Testicular ultrasonography and sex hormone examination were conducted before operation. F-S group met the indications for Fowler-Stephens surgical. In the first stage, the testicular vessels were doubly clipped at a site away from the testis in laparoscopic, and the second stage was scheduled about 6 months after the first stage. The children in the control group were treated with laparoscopic orchiopexy without disconnect spermatic vessels. The two groups were followed up to 6 months after the operation, and the testicular volume and sex hormone indexes of the two groups were measured. The testicular volume and sex hormones before and after the operation of the F-S group and the control group were respectively subjected to a self-control study, and a hormone comparison study was carried out between the two groups of children. Both the F-S group and the control group successfully fixed the testes in the scrotum without tension during the operation. In both groups, 20 cases of testicular positions were reexamined 6 months after the operation without retraction. All the patients had a viable testis in scrotum after operation. Two of F-S group had an atrophic testis in the scrotum, and the others had a good vascularization detected on echo color doppler ultrasound. The average testicular volume of F-S group was (0.34±0.16) ml before operation and the postoperative one was (0.38±0.13) ml, 0.089, 0.05. In control group, the preoperative average testicular volume was (0.40±0.14) ml, and postoperative one was (0.40±0.15) ml, 0.933, 0.05. The testicular volume of two group had no significant difference. Sex hormone reexamination: Testosterone (T), estradiol (E2) and luteinizing hormone (LH) did not change after operation. Prolactin (PRL) in F-S group was 13.44 μg/L before operation and 12.3 μg/L after operation, PRL in control group was from 15.45 μg/L to 10.34 μg/L, 0.732, the change of prolactin (PRL) has no significant difference. The median preoperative follicle stimulating hormone (FSH) in the F-S group was 1.18 U/L preoperatively and 1.61 U/L postoperatively; the median FSH of the control group was 1.21 U/L preoperatively and 1.1 U/L postoperatively. Compared between the two groups, the postoperative increase in the FS group was higher than that before the operation, 0.032, 0.05, the difference was statistically significant. The median of progesterone (PROG) in the F-S group was 0.25 nmol/L before operation and 0.17 nmol/L after operation; the median PROG of the control group was 0.56 nmol/L before operation and 0.24 nmol/L after operation. It was lower after the operation than before the operation, 0.034, 0.05, the difference was statistically significant. (1) Laparoscopic Fowler-stephens staging operation is an effective method for the treatment of patients with high cryptorchidism, and it is worthy of further promotion. (2) Disruption of spermatic cord vessels does have an impact on hormones changes. The choice of this surgical procedure should be carefully and fully evaluated.
评估两阶段腹腔镜Fowler-Stephens睾丸固定术治疗高位隐睾症的临床效果,并与不切断精索血管的腹腔镜睾丸固定术进行比较。对2015年1月至2019年4月采用两阶段Fowler-Stephens睾丸固定术治疗的20例高位隐睾症患儿进行回顾性分析(F-S组)。该组所有患儿均为单侧隐睾,年龄6至18个月,平均年龄13.5个月。左侧7例,右侧13例。选取同年龄组20例对照患儿,采用不切断精索血管的睾丸固定术治疗,年龄6至18个月,平均年龄12.5个月。左侧6例,右侧14例。术前进行睾丸超声检查和性激素检查。F-S组符合Fowler-Stephens手术指征。第一阶段,在腹腔镜下于远离睾丸处双重夹闭睾丸血管,第二阶段在第一阶段约6个月后进行。对照组患儿采用不切断精索血管的腹腔镜睾丸固定术治疗。两组术后随访6个月,测量两组患儿的睾丸体积和性激素指标。分别对F-S组和对照组手术前后的睾丸体积和性激素进行自身对照研究,并对两组患儿进行激素对比研究。F-S组和对照组手术中均成功将睾丸无张力地固定于阴囊内。两组术后6个月复查睾丸位置均无回缩,所有患者术后阴囊内睾丸均存活。F-S组2例阴囊内睾丸萎缩,其余经彩色多普勒超声检查血运良好。F-S组术前平均睾丸体积为(0.34±0.16)ml,术后为(0.38±0.13)ml,t=0.089,P>0.05。对照组术前平均睾丸体积为(0.40±0.14)ml,术后为(0.40±0.15)ml,t=0.933,P>0.05。两组睾丸体积差异无统计学意义。性激素复查:睾酮(T)、雌二醇(E2)和促黄体生成素(LH)术后均无变化。F-S组术前催乳素(PRL)为13.44μg/L,术后为12.3μg/L;对照组术前PRL为15.45μg/L,术后为10.34μg/L,t=0.732,催乳素(PRL)变化差异无统计学意义。F-S组术前促卵泡生成素(FSH)中位数为1.18U/L,术后为1.61U/L;对照组术前FSH中位数为1.21U/L,术后为1.1U/L。两组比较,F-S组术后升高高于术前,t=0.032,P<0.05,差异有统计学意义。F-S组术前孕酮(PROG)中位数为0.25nmol/L,术后为0.17nmol/L;对照组术前PROG中位数为0.56nmol/L,术后为0.24nmol/L。术后低于术前,t=0.034,P<0.0